HB-302

· Hookipa Biotech GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB-302, covering 2024-06-12 to 2024-06-12. Get the full timeline:

Most recent: Clinical Trial Update: HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]